BRAIN Biotech AG (FRA:BNN)

Germany · Delayed Price · Currency is EUR

2.740

-0.010 (-0.36%)

At close: Jun 26, 2026

35.64% (1Y)

Market Cap	60.74M +35.0%
Revenue (ttm)	48.31M -9.7%
Net Income	-11.02M
EPS	-0.51
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.740
Previous Close	2.750
Day's Range	2.740 - 2.740
52-Week Range	1.810 - 3.810
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bio... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1993

Employees 280

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol BNN

Financial Performance

In fiscal year 2025, BRAIN Biotech AG's revenue was 50.22 million, a decrease of -9.52% compared to the previous year's 55.50 million. Losses were -11.74 million, 5.53% more than in 2024.

Financial Statements